Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S10 pseudogene 2 (RPS10P2) is classified as a pseudogene, meaning it is a non-functional genomic DNA sequence similar to a functional gene, in this case, the ribosomal protein S10 gene[7][9]. Pseudogenes like RPS10P2 do not code for proteins and are usually considered ‘genetic fossils’—segments left over from gene duplication or retrotransposition events in evolution. Unlike the functional RPS10 gene (which codes for a component of the 40S ribosomal subunit and is involved in protein synthesis), RPS10P2 has no known protein product or physiological function and is not considered a therapeutic target[7][9]. There is no current evidence that RPS10P2 plays any direct role in disease, biological pathways, or as a biomarker, nor is there any known drug interaction[7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S10 pseudogene 2 (RPS10P2).